SEC Tracker
Get the app

AngioDynamics ANGO

AngioDynamics reports fiscal Q1 loss

Form
10-Q
Filed
Importance
Notable
  1. Net loss of $7.1 million for fiscal Q1 2027
  2. Revenue increased to $80.9 million from $75.7 million
  3. Operating loss narrowed to $7.3 million from $10.7 million
  4. Cash decreased to $33.97 million from $53.86 million

Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when AngioDynamics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Orthofix Medical OFIX public float $440M, Jun 30, 2025
  2. Axogen AXGN public float $431M, Jun 30, 2025
  3. Delcath Systems DCTH public float $420M, Jun 30, 2025
  4. Ceribell CBLL public float $417M, Jun 30, 2025
  5. Iradimed IRMD public float $481M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.